Saga Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 30-07-2024
- Paid Up Capital ₹ 1.00 Cr
as on 30-07-2024
- Company Age 5 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 25.06 Cr
as on 30-07-2024
- Satisfied Charges ₹ 5.00 Cr
as on 30-07-2024
- Revenue 42.05%
(FY 2023)
- Profit 66.74%
(FY 2023)
- Ebitda 73.37%
(FY 2023)
- Net Worth 104.09%
(FY 2023)
- Total Assets 25.19%
(FY 2023)
About Saga Lifesciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company currently has active open charges totaling ₹25.06 Cr. The company has closed loans amounting to ₹5.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Viranchi Shah, Vinit Shah, Rushabh Shah, and Three other members serve as directors at the Company.
- CIN/LLPIN
U24239GJ2019PLC109035
- Company No.
109035
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
10 Jul 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Saga Lifesciences?
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Viranchi Shah  | Director | 10-Jul-2019 | Current |
| Vinit Shah | Director | 10-Jul-2019 | Current |
| Rushabh Shah | Director | 10-Jul-2019 | Current |
| Ruchir Shah | Director | 10-Jul-2019 | Current |
| Vishal Haswani | Director | 24-May-2023 | Current |
| Sanjaykumar Shah | Director | 24-May-2023 | Current |
Financial Performance of Saga Lifesciences.
Saga Lifesciences Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 42.05% increase. The company also saw a substantial improvement in profitability, with a 66.74% increase in profit. The company's net worth Soared by an impressive increase of 104.09%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Saga Lifesciences?
In 2023, Saga Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Treecap Advisors Private LimitedActive 9 years 8 monthsVishal Haswani and Sanjaykumar Shah are mutual person
Seraga Lifesciences Private LimitedActive 6 years 8 monthsViranchi Shah, Rushabh Shah and 1 more are mutual person
- Saga Health Care Private LimitedActive 29 years 5 months
Viranchi Shah and Vinit Shah are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Sidbi Creation Date: 07 Nov 2023 | ₹20.00 Cr | Open |
Others Creation Date: 01 Nov 2021 | ₹4.50 Cr | Open |
Others Creation Date: 08 Jun 2021 | ₹0.46 M | Open |
How Many Employees Work at Saga Lifesciences?
Saga Lifesciences has a workforce of 179 employees as of Jul 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Saga Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Saga Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
